KT5823
KT5823, a selective the cGMP-dependent protein kinase (PKG) inhibitor with an Ki value of 0.23 μM, it also inhibits PKA and PKC with Ki values of 10 μM and 4 μM, respectively. KT5823 is a Staurosporine-related protein kinase inhibitor, increases thyroid-stimulating hormone-induced (Na+/I- symporter) NIS expression, and iodide uptake in thyroid cells. KT5823 arrests cells after the G0/G1 boundary and causes increases in the levels of apoptotic DNA fragmentation[1][2][3][4][5].
Product Specifications
CAS Number
[126643-37-6]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Antibiotic; Apoptosis; Bacterial; PKA; PKC
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis; Epigenetics; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/kt5823.html
Purity
99.90
Solubility
DMSO : ≥ 20mg/mL
Smiles
C[C@@]([C@@]1(OC)C(OC)=O)(O[C@](N2C3=C4C=CC=C3)([H])C1)N5C(C2=C4C6=C7CN(C)C6=O)=C7C8=C5C=CC=C8
Molecular Formula
C29H25N3O5
Molecular Weight
495.53
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKA; PKC
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items